4/3/26 21:30 | 4/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | S | -740 | 49.33 | 0 | -15 | -2 | 628 | D | | | | | | | | | | | | | | |
4/3/26 21:30 | 4/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Sloan Sheldon | MA | O | Chief Me | S.d | -398 | 50.00 | 0 | -8 | -100 | 0 | D | | | | | | | | | | | | | | |
4/3/26 21:29 | 4/1/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -370 | 49.34 | 0 | -8 | -7 | 98 | D | | | | | | | | | | | | | | |
3/3/26 21:32 | 3/3/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S.d | -102 | 40.65 | 0 | -3 | -2 | 98 | D | | | | | | | | | | | | | | |
3/3/26 21:31 | 3/2/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | S | -633 | 42.19 | 0 | -15 | -2 | 643 | D | | | | | | | | | | | | | | |
2/4/26 21:33 | 2/2/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | S | -492 | 32.80 | 0 | -15 | -2 | 658 | D | | | | | | | | | | | | | | |
1/6/26 21:36 | 1/2/26 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | S | -460 | 30.68 | 0 | -15 | -2 | 672 | D | | | | | | | | | | | | | | |
12/3/25 21:52 | 12/1/25 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | S | -435 | 29.02 | 0 | -15 | -2 | 687 | D | | | | | | | | | | | | | | |
11/5/25 21:15 | 11/3/25 | SYRE | Health | Drug | Pharmaceutical Preparations | Turtle Cameron | MA | DO | CEO | S | -1,050 | 23.33 | 0 | -45 | -6 | 702 | D | | | | | | | | | | | | | | |
9/3/25 18:53 | 9/2/25 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -300 | 16.26 | 0 | -18 | -16 | 98 | D | | | | | | | | | | | | | | |
11/8/24 16:53 | 11/6/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | | S | -246 | 36.76 | 0 | -7 | -20 | 27 | I | | | | | | | | | | | | | | |
10/28/24 16:41 | 10/25/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Albers Jeffrey W. | MA | D | | S | -11 | 36.43 | 0 | 0 | -1 | 34 | I | | | | | | | | | | | | | | |
9/5/24 16:04 | 9/3/24 | SYRE | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | MA | O | CFO | S | -522 | 28.17 | 0 | -19 | -14 | 116 | D | | | | | | | | | | | | | | |
9/28/18 17:11 | 9/27/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Schuchart Aaron | TX | O | Chief Bu | S | -57 | 9.50 | 0 | -6 | -71 | 3 | D | | | | | | | | | | | | | | |
5/14/18 16:01 | 5/11/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | V8 | T | | S | -197 | 10.06 | 0 | -20 | -1 | 2,175 | D | | | | | | | | | | | | | | |
5/11/18 16:28 | 5/9/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | V8 | T | | S.m | -748 | 10.12 | 0 | -74 | -3 | 2,195 | D | | | | | | | | | | | | | | |
5/9/18 16:01 | 5/7/18 | AGLE | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | V8 | T | | S.m | -424 | 10.06 | 0 | -42 | -2 | 2,269 | D | | | | | | | | | | | | | | |